Agios Pharmaceuticals reported $0 in Trade Debtors for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acceleron Pharma XLRN:US $ 39M 31M
Alexion Pharmaceuticals ALXN:US $ 1372.2M 27M
Alnylam Pharmaceuticals ALNY:US $ 579.12M 510M
Amgen AMGN:US $ 5366M 357M
AstraZeneca AZN:LN 6B 763M
Bayer BAYN:GR 1.57B 95.3M
Biogen BIIB:US $ 2552.1M 22.6M
Biomarin Pharmaceutical BMRN:US $ 381.22M 15.17M
Bluebird Bio BLUE:US $ 4M 1.6M
Bristol Myers Squibb BMY:US $ 7855M 435M
Daiichi Sankyo 4568:JP Y 243887M 65476M
Eli Lilly And LLY:US $ 5775.6M 576.9M
Exelixis EXEL:US $ 134M 3M
Gilead Sciences GILD:US $ 3194M 713M
GlaxoSmithKline GSK:LN 749.6M 139.9M
Immunogen IMGN:US $ 23.24M 7.8M
JAZZ PHA JAZZ:US $ 361.66M 9.74M
Merk MRK:US $ 7577M 605M
Novartis NOVN:VX 7.95B 843M
Novartis NVS:US $ 8299M 347M
Pfizer PFE:US $ 9128M 753M
Puma Biotechnology PBYI:US $ 27M 4M
Regeneron Pharmaceuticals REGN:US $ 2811.3M 121.9M
Sarepta Therapeutics SRPT:US $ 107M 2M
Seattle Genetics SGEN:US $ 293.42M 3.34M
Vertex Pharmaceuticals VRTX:US $ 791.77M 53.5M
YTE INCY:US $ 420.25M 68.73M